Quantgene

Principle 6/12
Universal Detection Starts with Genomics

A new type of genetic testing - Universal Genomics (UGx) - allow to both determine our lifetime cancer risk and detect active signals of over 50 cancer types in the blood stream with single-molecule precision (liquid biopsy).

Different from full body MRIs (FMx) that require patients to take a day off, travel to a clinical site and undergo a 2h process, genomics can be done in a 10 minute at-home blood draw.

UGx represents a seamless entry point into the Universal Cancer Detection matrix that patients can easily and seamlessly complete.

If signals are found, FMx and other precision diagnostics tools are used to quickly resolve any potential signal and threat.

By focusing on UGx first, universal detection systems like Quantgene QX reduce the price point of Universal Cancer Detection below $150 / mo while still leveraging the power of advanced diagnostics and imaging systems when needed. They unlock Universal Cancer Detection for all.

What do you think? Leave your comment below!

Invest in Quantgene: http://LetsEndCancer.com
Universal Cancer Detection. http://DontWait.Life!